The HRB observes policies on data protection and the use of health information in research.
A detailed explanation of the HRB policy on data protection and health information can be found belowClose
The HRB observes policies on alledged misconduct in applications to the HRB
A detailed explanation of the HRB policy for dealing with alleged plagerism in HRB grant applications can be found below
The Clinical Trials and Interventions Research Governance Policy sets out the HRB’s requirements for Host Institutions (“HIs”) before, during and after the conduct of clinical trials to ensure good research governance is adhered to.
This policy will form part of our grant general terms and conditions. This policy will cover clinical trials and interventions, including regulated and non-regulated trials, where the HRB is directly funding the trials through the following HRB schemes only:
- Definitive Interventions and Feasibility Awards (DIFA) and
- Clinical Trial Networks (CTNs); excluding Cancer Trials Ireland (CTI).
Clinical trials funded under the current CTI programme have a separate contract that governs CTI responsibilities. Similarly, clinical trials conducted in a HRB funded Clinical Research Infrastructure such as the HRB CRFs but not directly funded by the HRB, will have a separate contract.
In the HRB-MRCG Joint Funding scheme, the HRB and MRCG charities jointly select and fund research projects carried out in a research performing organisation, which is a HRB Host Institution.
The Co-Funding Partner Approval Policy reflects this relationship between the partners, and can be found below
The HRB expects all of the researchers that it funds, both clinical and non-clinical, to adhere to the highest standards of integrity in the conduct of their research
The HRB guidelines to host institutions for dealing with alleged misconduct in research can be found below